Drug
diclofenac epolamine
Marketed as LICART.
Generic name
diclofenac epolamine
Brand names
LICART
First FDA approval
2018-12-19
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA206976 | LICART | 2018-12-19 | IBSA INST BIO |
Manufacturers
IBSA INST BIO
Frequently asked questions
When was diclofenac epolamine FDA approved?
Earliest FDA approval on record: 2018-12-19.
What brand names are sold as diclofenac epolamine?
LICART.
Sources
Appeal a diclofenac epolamine denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com